Worthington, OH, United States of America

Jesse Kwiek

This inventor holds 2 USPTO granted patents. Top assignees: Duke University, The Ohio State University. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jesse Kwiek. Retrieved from https://idiyas.com/inventor/jesse-kwiek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jesse Kwiek: Innovator in Fatty Acid Synthase Inhibition

Introduction

Jesse Kwiek is a notable inventor based in Worthington, OH (US). She has made significant contributions to the field of biochemistry, particularly in the development of fatty acid synthase inhibitors. With a total of 2 patents, her work focuses on innovative methods for treating cancer and viral infections.

Latest Patents

Jesse Kwiek's latest patents revolve around the inhibition of Fatty Acid Synthase (FASN). The present disclosure relates to a method for inhibiting FASN with a FASN inhibitor. Additionally, her patents detail methods for treating cancer and viral infections using a FASN inhibitor, along with compounds and compositions that effectively inhibit FASN.

Career Highlights

Throughout her career, Jesse has worked with prestigious institutions such as Duke University and the Ohio State Innovation Foundation. Her research has garnered attention for its potential impact on therapeutic strategies in oncology and virology.

Collaborations

Jesse has collaborated with esteemed colleagues, including Timothy Haystead and Philip Floyd Hughes. These partnerships have further enriched her research and innovation in the field.

Conclusion

Jesse Kwiek stands out as an influential inventor in the realm of fatty acid synthase inhibitors. Her contributions are paving the way for new treatment options in cancer and viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…